Details for New Drug Application (NDA): 016131
✉ Email this page to a colleague
NDA 016131 describes CLOMID, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the CLOMID profile page.
The generic ingredient in CLOMID is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
The generic ingredient in CLOMID is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
Summary for 016131
| Tradename: | CLOMID |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | clomiphene citrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016131
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
